Mitch Gross, M.D., PhD

Dr. Gross is Research Director of the USC Westside Cancer Center and the Center for Applied Molecular Medicine and Associate Professor of Medicine and Urology at the Keck School of Medicine, University of Southern California. His research interest focuses on applying modern techniques relating to the study of genes and proteins (genomics and proteomics) on the clinical problems faced in treating cancer patients. A particular interest is to understand and apply new findings and therapies related to the androgen receptor (male hormones) and related proteins and pathways as treatment for prostate cancer. As a medical oncologist, his clinical activities are focused on clinical trials incorporating both molecularly targeted and conventional therapies to the care of cancer patients.

Dr. Gross has earned degrees from the University of California, San Diego (B.A.), Baylor College of Medicine in Houston (M.D.), and the University of California, Los Angeles (Ph.D. Molecular Biology). He completed a residency in internal medicine and a fellowship in hematology and medical oncology at the UCLA Center for the Health Sciences. Among the many academic honors awarded to Dr. Gross, he is particularly distinguished with membership in the Phi Beta Kappa and Alpha Omega Alpha honor societies. His research has been published in major biomedical research journals including Blood, Proceedings of the National Academies of Science, Oncogene, Clinical Cancer Research, among others.